Retained Earnings - Zhejiang Ausun Pharmaceutical Co Ltd (SSE:603229) - Alpha Spread

Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229

Watchlist Manager
Zhejiang Ausun Pharmaceutical Co Ltd Logo
Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
Watchlist
Price: 6.59 CNY -2.37% Market Closed
Market Cap: 5.5B CNY
Have any thoughts about
Zhejiang Ausun Pharmaceutical Co Ltd?
Write Note

Zhejiang Ausun Pharmaceutical Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Ausun Pharmaceutical Co Ltd
Retained Earnings Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Ausun Pharmaceutical Co Ltd
SSE:603229
Retained Earnings
ÂĄ1.1B
CAGR 3-Years
36%
CAGR 5-Years
35%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Retained Earnings
ÂĄ11.7B
CAGR 3-Years
36%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Retained Earnings
ÂĄ11.9B
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
26%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Retained Earnings
ÂĄ34.3B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
21%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Retained Earnings
ÂĄ20.1B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
10%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Retained Earnings
-ÂĄ1.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhejiang Ausun Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
1.1B CNY

Based on the financial report for Jun 30, 2024, Zhejiang Ausun Pharmaceutical Co Ltd's Retained Earnings amounts to 1.1B CNY.

What is Zhejiang Ausun Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
35%

Over the last year, the Retained Earnings growth was 27%. The average annual Retained Earnings growth rates for Zhejiang Ausun Pharmaceutical Co Ltd have been 36% over the past three years , 35% over the past five years .

Back to Top